Literature DB >> 12225357

Regulation of tumour immunity by CD25+ T cells.

Awen Gallimore1, Shimon Sakaguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12225357      PMCID： PMC1782775          DOI： 10.1046/j.1365-2567.2002.01471.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  42 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Authors:  M Itoh; T Takahashi; N Sakaguchi; Y Kuniyasu; J Shimizu; F Otsuka; S Sakaguchi
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.

Authors:  C A Piccirillo; E M Shevach
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 4.  Regulatory T cells in spontaneous autoimmune encephalomyelitis.

Authors:  G C Furtado; D Olivares-Villagómez; M A Curotto de Lafaille; A K Wensky; J A Latkowski; J J Lafaille
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

Review 5.  T cell defined tumor antigens.

Authors:  B J Van den Eynde; P van der Bruggen
Journal:  Curr Opin Immunol       Date:  1997-10       Impact factor: 7.486

6.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

7.  Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

Authors:  W F Ng; P J Duggan; F Ponchel; G Matarese; G Lombardi; A D Edwards; J D Isaacs; R I Lechler
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

Review 8.  Differentiation of T regulatory cells by immature dendritic cells.

Authors:  M G Roncarolo; M K Levings; C Traversari
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

9.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

10.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307
View more
  23 in total

Review 1.  Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.

Authors:  Steven De Vleeschouwer; Stefaan W Van Gool; Frank Van Calenbergh
Journal:  Childs Nerv Syst       Date:  2004-09-28       Impact factor: 1.475

2.  Characteristics of CD4+CD25+Foxp3+ regulatory T cells in patients with multiple organ dysfunction syndrome.

Authors:  Xiuxian Zang; Yanfang Jiang; Xiujiang Li; Yujun DU; Junqi Niu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

3.  Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes.

Authors:  Yoshiko Ota; Soichiro Ishihara; Kensuke Otani; Koji Yasuda; Takeshi Nishikawa; Toshiaki Tanaka; Junichiro Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Hiroaki Nozawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Mol Clin Oncol       Date:  2016-02-03

4.  Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity.

Authors:  Malcolm P MacConmara; Adrian A Maung; Satoshi Fujimi; Ann M McKenna; Adam Delisle; Peter H Lapchak; Selwyn Rogers; James A Lederer; John A Mannick
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

Review 5.  Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Wolfgang Dummer; Argyrios N Theofilopoulos
Journal:  Springer Semin Immunopathol       Date:  2005-01-22

Review 6.  Targeting regulatory T cells for improving cancer therapy: Challenges and prospects.

Authors:  Bilikere S Dwarakanath; Abdullah Farooque; Seema Gupta
Journal:  Cancer Rep (Hoboken)       Date:  2018-05-15

Review 7.  The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Authors:  Lana E Kandalaft; Nathan Singh; John B Liao; Andrea Facciabene; Jonathan S Berek; Daniel J Powell; George Coukos
Journal:  Gynecol Oncol       Date:  2009-12-02       Impact factor: 5.482

8.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Authors:  David H Munn; Madhav D Sharma; Deyan Hou; Babak Baban; Jeffrey R Lee; Scott J Antonia; Jane L Messina; Phillip Chandler; Pandelakis A Koni; Andrew L Mellor
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  Prognostic value of peripheral and local forkhead box P3+ regulatory T cells in patients with non-small-cell lung cancer.

Authors:  Takeo Hasegawa; Hiroyuki Suzuki; Takumi Yamaura; Satoshi Muto; Naoyuki Okabe; Jun Osugi; Mika Hoshino; Mitsunori Higuchi; Kazuya Ise; Mitsukazu Gotoh
Journal:  Mol Clin Oncol       Date:  2014-05-29

Review 10.  Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.

Authors:  Shirin Karimi; Subhasis Chattopadhyay; Nitya G Chakraborty
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.